Oren Gilad, President/CEO: Aprea Therapeutics APRE Buy · Filed 24/10/16

Trade details

Type: Insider buy
Amount: $725
Shares · price: 250 sh · $2.90 a share
Held after: 332,895 sh
Stock: Aprea Therapeutics APRE
Person: Oren GiladPresident/CEO
Trade date: 24/10/15
Filed: 24/10/16
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 4 insiders
Holding change: +0.1%

Aprea Therapeutics trades, last 26 weeks

What else happened in Aprea Therapeutics around then

Filed or reported within 30 days of the trade day · 24/09/15~24/11/14

Oren Gilad's recent trades

Oren GiladPresident/CEO
BuyAprea Therapeutics
Buy
Aprea Therapeutics
APRE
$25K
28,100 sh
$25K
Filed 02/02
Traded 01/30
Oren GiladPresident/CEO
BuyAprea Therapeutics
Buy
Aprea Therapeutics
APRE
$4,495
2,497 sh
$4,495
Filed 25/04/04
Traded 25/04/03
Oren GiladPresident/CEO
BuyAprea Therapeutics
Buy
Aprea Therapeutics
APRE
$5,616
3,003 sh
$5,616
Filed 25/04/04
Traded 25/04/03
Oren GiladPresident/CEO
BuyAprea Therapeutics
Buy
Aprea Therapeutics
APRE
$1,960
500 sh
$1,960
Filed 24/10/24
Traded 24/10/23
Oren GiladPresident/CEO
BuyAprea Therapeutics
Buy
Aprea Therapeutics
APRE
$2,590
1,000 sh
$2,590
Filed 24/10/15
Traded 24/10/14